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Abstract: 
The effect of energy, protein, fat, and phenylalanine on serum phenylalanine concentrations 
during pregnancy for a set of identical twins with phenylketonuria (PKU) was examined. Blood 
samples were collected one to two times per week. The subjects completed a 3-d food record 
prior to each blood collection. The effect of the factors on serum phenylalanine levels was 
evaluated statistically using time-series analysis. Dietary intakes of the nutrients evaluated were 
similar for the subjects. For one subject, there were highly significant effects of energy, protein, 
and fat on serum phenylalanine levels. In contrast, these nutrients had no significant effect on 
serum phenylalanine for the other subject. Dietary phenylalanine had no significant effect on 
serum phenylalanine for either twin. 
Conclusions: There was no effect of phenylalanine intake and no consistent effect of energy, 
protein, or fat on serum phenylalanine. Other dietary or environmental factors or a combination 
of factors may impact serum phenylalanine levels of pregnant women with PKU. 
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Article: 
Maternal phenylketonuria (PKU) refers to fetal damage from PKU in the pregnant woman. If 
untreated, women with PKU are at risk for giving birth to infants who are mentally retarded, 
microcephalic, of low birthweight, and have anomalies such as heart disease (1–3). It is 
recommended that serum phenylalanine levels be maintained between 120 mmol/L and 360 
mmol/L at conception and throughout pregnancy (4). The purpose of this study was to examine 
the impact of energy, protein, fat, and dietary phenylalanine intake on serum phenylalanine level 
during pregnancy for identical twin mothers with PKU. Both subjects were enrolled in the 
National Collaborative Maternal PKU Study. Additional samples were collected to provide a 
more extensive profile of results for our subjects. 
Patients and methods 
NC and CC were diagnosed with PKU at birth. Mutation analysis revealed the twins have the 
genetic compound status for two phenylalanine hydroxylase mutations, IVS-12ntl/R408W, both 
associated with classical PKU (5). Serum phenylalanine levels for these twins have been high 
and difficult to control throughout childhood. Despite low average cognitive scores (NC-80, CC-
74), the twins functioned well at home and in the community, planned their pregnancies together, 
and provided each other with emotional support to maintain the phenylalanine-restricted diet. 
These twins interacted several times a day, even during meals, and though one was of lower 
intellect, they functioned similarly. 
Height and pre-pregnancy weight were as follows: 170 cm, 56.2 kg for NC and 170 cm, 57.7 kg 
for CC. NC and CC had been off diet for several years prior to pregnancy. The subjects were 
instructed to resume the phenylalanine-restricted diet prior to conception and to obtain a serum 
phenylalanine level below 360 mmol/L on three consecutive samples before attempting 
pregnancy. Dietary treatment consisted of a phenylalaninefree medical formula, Phenex II (Ross 
Products Division, Abbott Laboratories, Columbus, OH), low protein foods (no more than 200 
mg phenylalanine per day), and fats and sugars for additional energy. 
Blood samples were collected one to two times per week throughout pregnancy. Serum was 
analyzed for total phenylalanine concentration by the standard fluorimetric method using 
ninhydrin (6). Subjects recorded all food (including free foods) and fluids consumed for three 
consecutive days prior to each blood collection. Food records were analyzed for dietary 
phenylalanine, energy, protein, and fat using the Amino Acid Analyzer Software (Version 2.3, 
Ross Products Division, Abbott Laboratories, Columbus, OH). Nutrition counseling was 
provided when serum phenylalanine levels were elevated or when weight gain did not follow 
recommendations (7). 
The effect of energy, protein, fat, and phenylalanine on serum phenylalanine during pregnancy 
was evaluated statistically using time-series analysis (8) (SPSS statistical software version 7.5). 
Analyses were completed separately for each subject and each nutrient. Data that are collected 
repeatedly over time from the same subject are usually correlated and thus violate the assumption 
of independence that underlies general linear model statistical techniques such as regression and 
analysis of variance. Time-series analysis is a statistical technique appropriate for analyzing data 
that are serially correlated. The analysis provides an estimate and a statistical test of the relation 
between the dependent variable and the independent variable that is similar in interpretation to 
the estimates obtained in multiple regression. However, it is a more accurate test because the 
correlation is taken into consideration and does not inflate the value of the test statistic. 
 
To determine more specifically the nature of the time-series process, graphs of the 
autocorrelations between the data points are examined. Specific patterns in the graphs are 
indicative both of the type of process (autoregressive or moving average) and of the order of the 
process (whether the data points are correlated at time lag 1, time lag 2, etc.). We determined that 
the process was an autoregressive process in which a data point was related only to the 
immediately preceding data point (order 1), commonly referred to as a first-order autoregressive 
process or AR (1). A test of the autoregressive parameter indicated that the autocorrelation was 
statistically significant at the 0.05 level (another indication that the autoregressive model was 
appropriate). 
Having appropriately modeled the correlation in the data, we next estimated the effect of 
individual nutrients on serum phenylalanine. An effect was considered to be statistically 
significant if the probability value was less than 0.05. The B0 represents the mean level serum 
phenylalanine when the nutrient has the value of zero; it is the intercept term in a regression 
analysis. The B1 is the regression coefficient for the nutrient, representing the amount by which 
the serum phenylalanine level changes for each one unit change in the nutrient level. 
Results 
Total pregnancy weight gain was 16.9 kg for NC and 15.2 kg for CC. VC and AC, female 
offspring, were delivered by normal spontaneous vaginal delivery. Genetic testing revealed VC 
had R408W and AC had IVS-12ntl phenylalanine hydroxylase mutations (5) but serum 
phenylalanine levels were normal (9). Results of the effect of dietary factors on serum 
phenylalanine levels are presented in Table 1 and Fig. 1. Serum phenylalanine fluctuated greatly, 
with serum phenylalanine levels for NC averaging 411 _ 278 mmol/L and for CC averaging 744 
_ 387 mmol/L during pregnancy. 
For NC, there were highly significant effects of energy, protein, and fat on serum phenylalanine 
levels, whereas for CC no significant effect was observed (Table 1). Dietary phenylalanine 
intake had no significant effect on serum phenylalanine for either subject. Intakes of energy, 
protein, and fat were similar, yet NC had serum phenylalanine levels that were one-half those of 
CC, suggesting NC had greater phenylalanine tolerance. As shown in Fig. 1, both subjects tended 
to have lower serum phenylalanine levels after about weeks 19–20 of pregnancy, although their 
concurrent phenylalanine intake was not markedly different than during earlier pregnancy. 
However, the presence of greater phenylalanine tolerance in later pregnancy could not be 
statistically evaluated due to the small number of data points. 
Table 1. Contributions to serum phenylalanine (Phe) during pregnancy. 
 
1 Mean  SD for entire pregnancy: n = 43 for NC and n = 47 for CC. 
2 B0 is the theoretical serum Phe level without that nutrient contribution. 
3 B1 is the amount by which the theoretical serum Phe level would change due to that nutrient. 
 
Fig. 1. Serum phenylalanine (Serum Phe, mmol/L), phenylalanine intake (Phe intake, gm/d), and 
protein intake (gm/d) throughout pregnancy for NC (A) and CC (B). Phenylalanine and protein 
intakes are the average of 3 d. Serum phenylalanine was determined on the third day of food 
intake records 
Discussion 
A simple explanation for the differing statistical results between the two subjects could be that 
the food reports for NC may be better reflections of her intake than for CC. However, our results 
provide evidence to suggest that other factors may be involved. The reasons are as follows: NC 
gained 16.9 kg during pregnancy while CC gained 15.2 kg. CC’s child (VC) weighed 427 g less 
than NC’s child, had a 1 cm lower head circumference, and 1 cm greater body length. The 
relatively small difference in pregnancy weight gain between the twins (1.7 kg) does not explain 
the greater difference in infant outcome, particularly because both subjects gained adequate 
overall weight during pregnancy. CC’s poorer serum phenylalanine control during pregnancy 
may in part explain her child’s lower birthweight and head circumference. Because the subjects 
were so close emotionally and interacted so frequently (many times in a day including at meals), 
similarly accurate food records for the two subjects are likely. These subjects were also very 
consistent in providing detailed food records throughout pregnancy. 
The effect of individual nutrients and other factors on serum phenylalanine levels has been 
previously reported, although the literature citations are few. Dietary phenylalanine intake had no 
effect on serum phenylalanine level during pregnancy for either subject, which is consistent with 
a prior report of pregnant women with PKU (10). Consistent with our observation for NC, 
several investigators (10–12) reported a negative correlation between protein intake and plasma 
phenylalanine level in pregnant women with PKU. MacDonald and co-workers (13) reported that 
timing of medical formula consumption had a greater impact on serum phenylalanine than did 
dietary phenylalanine or energy intake. In our study, both subjects consumed equal volumes of 
their medical formula with each meal. 
Matalon et al. (14) reported maternal blood phenylalanine, weight gain, and energy intake had 
significant interactive effects on birth measurements of offspring, suggesting several factors 
probably interact to impact serum phenylalanine levels. The total number of data points for our 
study was greater than 40 for both subjects, and is considered adequate for time-series analysis 
for individual nutritional factors. However, an analysis of multiple nutrients on the serum 
phenylalanine level would have required a larger number of data points, thus could not be 
completed. We were also unable to analyze the effects of nutrients during early pregnancy versus 
late pregnancy or among trimesters due to insufficient data points. 
In conclusion, there was no effect of dietary phenylalanine intake and no consistent effect of 
energy, protein, and fat intake on serum phenylalanine for our subjects during pregnancy. Since 
our subjects were identical twins, one would assume that their serum phenylalanine 
concentrations would respond similarly to a given set of circumstances such as similar intakes of 
energy, protein and fat and the even distribution of formula throughout the day. However, NC 
had serum phenylalanine levels that were about one-half that of CC. Although there is the 
possibility that NC’s food records were more accurate than that of CC’s, our results suggest that 
there may be other factors or interactions among factors that impact serum phenylalanine levels 
of pregnant women with PKU. 
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